Company

Serinus Biosciences

Biotechnology Research 5 employees

Employees: 5
Contacts: 3
Emails: 3
Phones: 1

www.serinus.bio LinkedIn Crunchbase

Serinus Biosciences Overview

Website: www.serinus.bio
Industry: Biotechnology Research
Employees: 5
Founded: 2022
Funding: 150.0K
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Precision medicine Cancer biology AI/ML Computational biology Drug development Protein-protein interactions GenAI Small molecules

About Serinus Biosciences

Serinus Biosciences is an AI drug discovery company designing small molecule disrupters for protein-protein interactions (PPI). Our proprietary proteome-wide interface energetics map transforms any natural protein ligand into a small molecule binding opportunity. With over 60% of the proteome estimated to have binding hot loops at small molecule scale, we are geared to reveal orthosteric docking sites in tens of thousands of previously undruggable targets. Together with our PPI-specific generative AI engine, we design potent and synthetically accessible interface binding hits in months instead of years.

Serinus Biosciences Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Serinus Biosciences Org Chart

Sample employees and titles

Name	Title	Location	Contact
Chandni Khandwala	Phd in Biochemistry - Scientist	San Francisco Bay Area, United States	Email Phone
Maxwell Sherman	Co-founder & CTO @ Serinus Biosciences		View
Sabine Ruppel		Cambridge, Massachusetts, United States	Email
Adam Yaari	Co-founder & CEO @ Serinus Biosciences	New York, United States	Email